Tuesday 9th December 2014
On the basis of a cursory glance of the price chart, you may reckon on Aberdeen Asset Management (ADN, mkt cap £6bn), having a third pop at 500p/shr.
|Aberdeen Asset Management share price|
However, ADN's management can't put too much faith in this. They lobbed out over 3 million shares between them early last week.
|ADN Director sales after update|
Indeed, approaching 500p/shr appears to have been the magic number to exit stage left over recent years.
|ADN director sales/purchases over recent years|
Lastly, I'm minded to observe the CitiFX Emerging Market Carry Beta Index (CAFZBET4 Index). This leads me to believe that ADN is only going one way; perhaps 400p/shr for starters. So I sold short at 452p/shr.
|ADN as compared to CitiFX Emerging Market Beta Index|
Disclaimer: The information, discussions or topics referred to on this blog should in no way be considered “advice” to buy or sell anything. The information which may be referred to is freely available in the public domain and where required the source of information is referenced to for verification. While every effort has been made to ensure the veracity of any information contained within this blog, the author accepts no responsibility for the accuracy of any information contained within this blog or for the sources of information which may be referred to. Readers are responsible for their own actions and interpretation of the information contained within this blog.